Re: What is the status of ETC-216/ other plaque reduction meds?

On 20 Jan '07, "mike e" wrote:
Does anyone have any idea where Pfizer is at with regard to the
following?
"ETC-216 is an investigational drug is actually a synthetic form of HDL
cholesterol.

I saw this in a 11/30/06 Forbes article:
"Another drug that has been delayed because of manufacturing issues is
ETC-216, an injected compound to clear plaque from arteries; it could
enter large scale trials within a year, Pfizer said."

That's about all it says but here's the article if you'd like to see:
http://www.forbes.com/business/2006/11/30/pfizer-drug-pipeline-biz-cz_rl_1130drugs.html

Port
.

Loading